Sanofi announces €300 million collaboration with Blackstone Life Sciences to advance an innovative treatment for multiple myelomaInvestment will accelerate the overall Sarclisa® development programSanofi will continue to fully manage the clinical program and retain full rights and control of Sarclisa&.